您的购物车当前为空
LY3143921 ((S)-Example 2) hydrate 是一种具有口服活性的 CDC7激酶抑制剂。LY3143921 hydrate 表现出广泛的体外抗癌活性。

LY3143921 ((S)-Example 2) hydrate 是一种具有口服活性的 CDC7激酶抑制剂。LY3143921 hydrate 表现出广泛的体外抗癌活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 358 | In Stock | |
| 5 mg | ¥ 897 | In Stock | |
| 10 mg | ¥ 1,350 | In Stock | |
| 25 mg | ¥ 2,280 | In Stock | |
| 50 mg | ¥ 3,390 | In Stock | |
| 100 mg | ¥ 4,830 | In Stock |
LY3143921 hydrate 相关产品
| 产品描述 | LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1]. |
| 靶点活性 | Cdc7:3.3 nM, pMCM2:290 nM |
| 分子量 | 327.31 |
| 分子式 | C16H14FN5O2 |
| CAS No. | 1627696-53-0 |
| Smiles | C[C@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F.O |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 65 mg/mL (198.59 mM), Sonication is recommended. Ethanol: 32 mg/mL (97.77 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容